Pelvic Mass Lesions in Females: Tissue Characterization Capability of MRI

Shaha, Pramod; Khetawat, Rahul; Sahoo, Kulamani; Garg, Ashish; Ilyas, Mohd; Garg, Sahil; Budgemwar, Shree Hari

doi:10.7860/jcdr/2017/26030.10182

Cited by 4 publications

(6 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The majority of patients (58%) had unilateral adnexal mass lesions, and 42% had bilateral lesions which correlated with Shaha PR et al, right-sided adnexal lesions were 23 out of the total 50, 15 were left adnexal lesions, and eight bilateral. The laterality of four lesions that crossed the midline could not be determined due to their large size, and the ovaries could not be seen independently [7].…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Comparison of Ultrasound and MRI Findings in the Evaluation of Pelvic masses/lesions with Histopathological Correlation in Female Patients

Kaushal¹,

Maravi²,

Goyal³

et al. 2022

IJMAHS

View full text Add to dashboard Cite

Background- In this prospective study, we evaluated the role of magnetic resonance cholangiopancreatography (MRCP) as an imaging modality for identification and characterization of various pancreaticobiliary pathologies and to correlate MRCP findings with ultrasound (USG) findings. Methodology–This study was carried out as an observational study in Department of Radiodiagnosis, GMC Bhopal, for a study period of 20 months on patients suspected with pancreaticobiliary pathologies reporting for ultrasound examination. MRCP was performed following Ultrasound imaging (USG) with subsequent comparison of findings. Results- The sensitivity, specificity and diagnostic accuracy of ultrasound in detection of CBD dilatation were 86.21%. 100% and 92% respectively. The sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) and diagnostic accuracy of ultrasound in detection of intrahepatic biliary radicle (IHBR) dilatation was 81.97%. 97.44%. 98.04%. 77.55% and 88% respectively. The sensitivity of USG for identification of benign lesions was 93.55% whereas that for malignant lesions was 96.15%. Overall, diagnostic accuracy of USG for identification of benign and malignant lesions was 84% and 87% respectively. Conclusion– Although abdominal ultrasound continues to serve as a screening tool for detection of pancreaticobiliary pathologies and allows for differentiation between surgical and non-surgical causes of obstructive jaundice, the in-depth characterization of lesions as provided by magnetic resonance imaging (MRI) with MRCP suggests that it serves as an indispensable adjunct to endoscopic retrograde cholangiopancreatography (ERCP). MRCP with MRI serves as an accurate and non-invasive, non-ionizing imaging method for evaluation of biliary anatomy and pathology especially in cases of obese patients where ultrasound results are compromised.

show abstract

Section: Discussionmentioning

confidence: 99%

“…Shaha PR et al [7], concluded that among the uterine lesions, and uterine fibroids, only 16 (33%) were diagnosed with USG while 22 (46%) were diagnosed by MRI. MRI is an excellent ally in the identification of leiomyomas, with a specificity of 100 percent, accuracy of 97 percent, and sensitivity of 86-92 percent [14].…”

Section: Discussionmentioning

confidence: 99%

Comparison of Ultrasound and MRI Findings in the Evaluation of Pelvic masses/lesions with Histopathological Correlation in Female Patients

Kaushal¹,

Maravi²,

Goyal³

et al. 2022

IJMAHS

View full text Add to dashboard Cite

show abstract

“…[5,6,15,16] Moreover, MRI has high accuracy for differentiating benign and malignant ovarian tumors. [17] Regarding serum markers, patients with metastases showed lower levels of serum CA125 (<80 U/mL), higher levels of serum CA153 (>100 U/mL), and lower BRCA mutation probability (<20%) than patients with primary ovarian tumors. [18] However, regular screening of serum markers such as CA125 or CA153 is not recommended as they lack sensitivity.…”

Section: Discussionmentioning

confidence: 99%

Ovarian metastasis from breast cancer in three Chinese females

et al. 2019

View full text Add to dashboard Cite

Rationale:The biological behavior and clinical features of ovarian metastasis from breast cancer remain unclear; diagnosis and treatment of this condition are challenging.Patient concerns:We reported three cases of ovarian metastasis from breast cancer in Chinese women aged 44, 46, and 30 years. The prognosis was different in all three patients; however, no symptoms of ovarian metastasis were observed.Diagnosis:All three premenopausal patients were diagnosed with hormone receptor-positive breast cancer and two of them had axillary lymph node metastasis. All three women had multiple extra-ovarian metastases when ovarian metastasis was detected.Interventions:All patients received systemic antitumor therapy and underwent bilateral ovariectomy.Outcomes:Patient 1 had stable bone metastasis; patient 2 had stable lung metastasis and died of heart disease, and patient 3 had multiple brain metastases, which suggested poor outcomes.Lessons:It is important to screen for ovarian metastasis from breast cancer when evaluating suspicious ovarian masses detected via transvaginal ultrasound in patients with a breast cancer history. Therefore, we recommend simple laparoscopic bilateral oophorectomy not only for pathological diagnosis but also for metastatic tumor removal and therapeutic castration. In such cases, systemic therapy is essential because ovarian metastasis is often a component of systemic metastatic disease.

show abstract

“…1,2 The term mass is used to describe an abnormal area observed during routine physical examination or during imaging testing. 3,4 The term mass can be inferred to benign cyst, an enlarged ovary or a tumor that can be cancerous or noncancerous. [2][3][4] Pelvic masses may be of gynecologic origin and originate from gynecologic organs such as uterus, cervix and uterine adnexa or it can be of non-gynecologic origin and may originate for pelvic organs like bladder, intestines, ureters and renal organs.…”

Section: Introductionmentioning

confidence: 99%

“…3,4 The term mass can be inferred to benign cyst, an enlarged ovary or a tumor that can be cancerous or noncancerous. [2][3][4] Pelvic masses may be of gynecologic origin and originate from gynecologic organs such as uterus, cervix and uterine adnexa or it can be of non-gynecologic origin and may originate for pelvic organs like bladder, intestines, ureters and renal organs. For treatment and management efficiency in pelvic masses, it is necessary to determine whether the mass is benign or malignant.…”

Section: Introductionmentioning

confidence: 99%

Role of sonography in the assessment of pelvic masses in women and its histopathological correlation

Saifi¹,

Karikazi²,

Shetty³

2022

Int J Res Med Sci

View full text Add to dashboard Cite

Background: Abnormal growth of tissues in gynecologic pelvic organs like uterus, cervix or uterine adnexa are termed as female pelvic masses. Pelvic masses can be benign or malignant in nature. An efficient non-invasive treatment modality is essential for effective management and efficient treatment of pelvic masses. Current investigation is aimed towards estimating the sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of ultrasonography in diagnosing pelvic masses and differentiating benign and malignant pelvic masses.Methods: A descriptive study was conducted on 100 volunteers for 12 months at ultrasound department of radio-diagnosis in a tertiary care center. Patients were examined through transabdominal ultrasonography, covering entire pelvis. Morphology of pelvic lesions were examined in longitudinal and transverse planes through Doppler coupled with ultrasonography. Post-surgery histopathological examination reports were correlated with pre-operative imaging findings.Results: Majority of patients included in current study belonged to <40 years of age group and exhibited benign pelvic masses. Sensitivity and specificity of ultrasound in diagnosing benign masses was observed to be 87.5 and 70 respectively with PPV of 92.1 and NPV of 58.3. Majority of benign lesions were hypoechogenic, whereas malignant lesions were of mixed echogenicity. Most of the malignant lesions showed echogenic focus significantly different from malignant lesions.Conclusions: Ultrasonography was concluded to be primary modality and best screening tool for evaluation of pelvic masses with high sensitivity and specificity for correctly diagnosing and differentiating benign and malignant pelvic lesions. Ultrasonography coupled with color Doppler was efficient in determining the morphological characteristics of pelvic masses.

show abstract

Pelvic Mass Lesions in Females: Tissue Characterization Capability of MRI

Cited by 4 publications

References 16 publications

Comparison of Ultrasound and MRI Findings in the Evaluation of Pelvic masses/lesions with Histopathological Correlation in Female Patients

Comparison of Ultrasound and MRI Findings in the Evaluation of Pelvic masses/lesions with Histopathological Correlation in Female Patients

Ovarian metastasis from breast cancer in three Chinese females

Role of sonography in the assessment of pelvic masses in women and its histopathological correlation

Contact Info

Product

Resources

About